Biallelic CYP24A1 variants presenting during pregnancy: clinical and biochemical phenotypes.
AuthorsGriffin, Tomás P
Joyce, Caroline M
Blake, Liam M
O'Keeffe, Derek T
Islam, Md Nahidul
Dennedy, Michael C
Gillan, John E
Morrison, John J
Sayer, John A
O'Shea, Paula M
MetadataShow full item record
AbstractIntroduction: Inactivating mutations in CYP24A1, encoding vitamin D-24-hydroxylase, can lead to an accumulation of active vitamin D metabolites and consequent hypercalcaemia. Patient (infantile and adult) presentation is varied and includes mild-severe hypercalcaemia, hypercalciuria, nephrocalcinosis and nephrolithiasis. This study aimed to characterize the clinical and biochemical phenotypes of a family with two CYP24A1 missense variants. Methods: The proband and seven family members underwent detailed clinical and biochemical evaluation. Laboratory measurements included serum calcium, intact parathyroid hormone (iPTH), vitamin D metabolites and urine calcium and creatinine. Results: The proband presented during the second trimester of a planned pregnancy with flu-like symptoms. Laboratory tests showed elevated adjusted calcium of 3.27 (upper reference limit (URL: 2.30) mmol/L), suppressed iPTH (<6 ng/L), elevated 25(OH)D (264 (URL: 55) nmol/L) and elevated 1,25(OH)D (293 (URL: <280) pmol/L). Ionized calcium was 1.55 (URL: 1.28) mmol/L. Sanger sequencing revealed two heterozygous missense variants in the CYP24A1: p.(Arg439Cys), R439C and p.(Trp275Arg), W275R. The proband's brother and sister had the same genotype. The brother had intermittent hypercalcaemia and hypervitaminosis D. Only the sister had a history of nephrolithiasis. The proband's daughter and two nephews were heterozygous for the R439C variant. The proband and her brother frequently had elevated 25(OH)D:24,25(OH)2D ratios (>50) during follow-up. Conclusions: W275R is a new pathogenic CYP24A1 mutation in compound heterozygotic form with R439C in this family.
- Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1.
- Authors: Arnold N, O'Toole V, Huynh T, Smith HC, Luxford C, Clifton-Bligh R, Eastman CJ
- Issue date: 2019 Nov 21
- Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect.
- Authors: O'Keeffe DT, Tebben PJ, Kumar R, Singh RJ, Wu Y, Wermers RA
- Issue date: 2016 Oct
- Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
- Authors: Dinour D, Beckerman P, Ganon L, Tordjman K, Eisenstein Z, Holtzman EJ
- Issue date: 2013 Aug
- Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
- Authors: Cools M, Goemaere S, Baetens D, Raes A, Desloovere A, Kaufman JM, De Schepper J, Jans I, Vanderschueren D, Billen J, De Baere E, Fiers T, Bouillon R
- Issue date: 2015 Dec
- Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic Findings.
- Authors: Lenherr-Taube N, Young EJ, Furman M, Elia Y, Assor E, Chitayat D, Uster T, Kirwin S, Robbins K, Vinette KMB, Daneman A, Marshall CR, Collins C, Thummel K, Sochett E, Levine MA
- Issue date: 2021 Sep 27